Esketamine is a derivative of ketamine, an anesthetic that has been used for decades. However, esketamine has been specifically developed and approved by regulatory authorities, such as the U.S. Food and Drug Administration (FDA), for the treatment of TRD. It works by targeting the brain’s glutamate system, which is believed to be involved in the regulation of mood and emotions. visit now- https://ketamineonlinestore.org/2023/05/29/esketamine-nasal-spray-a-promising-solution-for-treatment-resistant-depression/
